MimiVax, Inc. logo

MimiVax, Inc.

Disrupting Cancer with Immunotherapy

3 employees · est. 2012 · Buffalo, United States

VS
Simcha Therapeutics logo

Simcha Therapeutics

Overcoming biological challenges in clinically translatable pathways.

15 employees · est. 2018 · New Haven, United States

MimiVax, Inc. is the older company (2012 vs 2018); Simcha Therapeutics is the larger of the two.

Side-by-Side Comparison

MimiVax, Inc. Simcha Therapeutics
Founded
2012 older 2018
Headquarters
Buffalo, United States New Haven, United States
Employees
3 15 larger
Industry
Biopharma, Biotechnology, Pharmaceutical Biotechnology, Health and Wellness, Life Sciences
Funding Stage
Series Unknown Series B
Total Funding
$16.55M $65.00M
Funding Rounds
4 2
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Immunotherapy, Cancer Treatment, Clinical-stage Company, Immunotherapeutic Vaccines, Targeted Therapies, Survivin-targeting Technology, Glioblastoma, Multiple Myeloma, Neuro-Endocrine Tumors, Pediatric High Grade Glioma, Medulloblastoma, DIPG, Oncology, Pharmaceutical Development Biopharmaceutical, Immunobiology, Cytokine Therapeutics, Engineered Cytokines, Oncology, Clinical-stage, Immunotherapy, Cancer Treatment, Precision Medicine, Biological Challenges, Immune System Modulation, Clinical Trials, Solid Tumors, Immune-biology, Disease-modifying Therapy
Website
mimivax.com simchatx.com
MimiVax, Inc. logo

About MimiVax, Inc.

MimiVax, Inc. is a privately held, clinical-stage biotechnology company founded in 2012 with a vision to disrupt cancer through highly innovative immunotherapies. The company's lead immunotherapeutic vaccine, , has shown promise by completing a Phase 2a clinical trial in adults with newly diagnosed...

Simcha Therapeutics logo

About Simcha Therapeutics

Simcha Therapeutics is a clinical-stage biotechnology startup founded in 2018 and headquartered in the United States. The company's slogan "Overcoming biological challenges in clinically translatable pathways" reflects its focus on pioneering first-in-class engineered cytokine therapeutics. Their le...

We will tell you when either one moves

BounceWatch watches MimiVax, Inc. and Simcha Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at MimiVax, Inc. and Simcha Therapeutics — by email.

Frequently Asked Questions

MimiVax, Inc. — Disrupting Cancer with Immunotherapy. Simcha Therapeutics — Overcoming biological challenges in clinically translatable pathways.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
MimiVax, Inc. has raised $16.55M while Simcha Therapeutics has raised $65.00M.
MimiVax, Inc. and Simcha Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare MimiVax, Inc. with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at MimiVax, Inc. on 12 Sep 2024, and Simcha Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy